How Compounding Pharmacies Fill Critical Gaps in Pediatric Drug Development Processes: Suggested Regulatory Changes to Meet Future Challenges
Drugs administered to children in the United States fall into two broad categories: (1) those that have followed the US Food and Drug Administration (US-FDA) pediatric drug approval process and are marketed as finished dosage forms with pediatric labeling; and (2) all others, many of which are used...
Saved in:
Main Authors: | Robert B. MacArthur (Author), Lisa D. Ashworth (Author), Keming Zhan (Author), Richard H. Parrish (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Compounded Nonsterile Preparations and FDA-Approved Commercially Available Liquid Products for Children: A North American Update
by: Richard H. Parrish, et al.
Published: (2022) -
Advanced pharmacy practice experiences (APPE) in academia as strategy to fill the gap on transgender health
by: Jonathan Figueroa-Colon, et al.
Published: (2020) -
Bleeding in Critically Ill Children-Review of Literature, Knowledge Gaps, and Suggestions for Future Investigation
by: Adi Avniel Aran, et al.
Published: (2021) -
Global Fund: the gap to fill
by: Robert Walgate -
Filling the Gaps in Educational Technology Research
by: Michele Jacobsen, et al.
Published: (2007)